| Precision Therapeutics is a CLIA-certified clinical laboratory |
Pancreatic Cancer
Pancreatic cancer begins in the tissues of the pancreas. There are two types of pancreatic tumors, exocrine and endocrine. Exocrine tumors are more common and often cancerous. Pancreatic cancer tends to spread rapidly and is usually not detected in its early stages because of a late onset of symptoms. The exact cause of pancreatic cancer is unknown, but there are certain risk factors including smoking, diet, diabetes and family history.
Pancreatic Cancer Treatment Options
Treatment options are determined by the type and stage of pancreatic cancer and include surgery, chemotherapy and radiation therapy. Sometimes a combination of these cancer treatments will be utilized. Because pancreatic cancer spreads quickly and is not easily detected in its early stages, surgical removal is not always possible. This leaves patients to rely primarily on radiation and chemotherapy.
Pancreatic Cancer and ChemoFx®
For pancreatic cancer patients receiving chemotherapy, whether as adjuvant chemotherapy, primary chemotherapy or combination chemotherapy, ChemoFx® can assist physicians in selecting personalized cancer treatment plans. Physicians can use ChemoFx® as a guide by testing multiple chemotherapy drugs on a patient's cancer cells before choosing one for their patient, giving patients a powerful advantage in their fight against cancer. For more information on ChemoFx® , visit http://www.chemofx.com.
Information for this webpage was gathered from the following websites:
www.Pancreatic.org
www.cancer.gov
www.mayoclinic.com
www.cancer.org
www.chemofx.com